LASCO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 3.751
EU - Europa 3.279
AS - Asia 1.327
SA - Sud America 9
AF - Africa 8
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.377
Nazione #
US - Stati Uniti d'America 3.723
IE - Irlanda 1.081
SE - Svezia 936
CN - Cina 804
IT - Italia 402
SG - Singapore 395
DE - Germania 268
FI - Finlandia 141
UA - Ucraina 124
GB - Regno Unito 93
FR - Francia 80
IN - India 62
PL - Polonia 62
BE - Belgio 33
HK - Hong Kong 26
CA - Canada 22
NL - Olanda 11
CZ - Repubblica Ceca 10
RU - Federazione Russa 10
CL - Cile 7
TR - Turchia 7
VN - Vietnam 7
CU - Cuba 6
EG - Egitto 5
ID - Indonesia 5
JP - Giappone 5
LT - Lituania 5
CH - Svizzera 4
KR - Corea 4
AL - Albania 3
BG - Bulgaria 3
IQ - Iraq 3
IR - Iran 3
SN - Senegal 3
BR - Brasile 2
DK - Danimarca 2
ES - Italia 2
HU - Ungheria 2
NO - Norvegia 2
RO - Romania 2
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
Totale 8.377
Città #
Dublin 1.080
Chandler 781
Nyköping 514
Jacksonville 371
Singapore 317
Beijing 287
Ashburn 208
Princeton 194
Dearborn 189
Medford 153
Ann Arbor 145
Messina 142
Cambridge 133
Bremen 124
Des Moines 117
Boardman 101
New York 90
Jinan 66
Shenyang 57
Warsaw 57
Munich 51
Nanjing 50
San Mateo 48
Wilmington 46
Pune 41
Tianjin 41
Lancaster 36
Woodbridge 36
Brussels 32
Helsinki 32
Hebei 28
Haikou 26
Seattle 25
Zhengzhou 25
Guangzhou 24
Hangzhou 24
Nanchang 23
Los Angeles 22
Houston 21
Taizhou 21
Catania 20
Strasbourg 18
Ningbo 16
Fuzhou 15
Hyderabad 15
Jiaxing 14
Taiyuan 12
Lanzhou 11
Brno 10
Fremont 10
Milan 10
Rome 9
Changsha 8
Lentini 8
Ottawa 8
Toronto 8
Central 7
Sheung Shui 7
Dong Ket 6
Fiumefreddo Di Sicilia 6
Frankfurt am Main 6
Leawood 6
Rende 6
Washington 6
Auburn Hills 5
Bydgoszcz 5
Clearwater 5
Jakarta 5
London 5
Redwood City 5
Santa Clara 5
Turin 5
Aci Sant'antonio 4
Camagüey 4
Cosenza 4
Falls Church 4
Hefei 4
Istanbul 4
Norwalk 4
Amsterdam 3
Augusta 3
Bagheria 3
Caltagirone 3
Chengdu 3
Izmir 3
Milazzo 3
Piazza Armerina 3
Riva 3
Sheffield 3
Sofia 3
Archi 2
Ardabil 2
Birmingham 2
Brescia 2
Bronte 2
Budapest 2
Cave 2
Ceccano 2
Centuripe 2
Changle 2
Totale 6.141
Nome #
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 105
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 93
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 92
Hyponatremia as a leading sign of hypopituitarism 91
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 90
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 89
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 86
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 85
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 85
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 84
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 82
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 80
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 79
null 78
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 77
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 75
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 75
IL-22 circulating serum levels in centenarians. 74
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 72
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 71
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 71
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 70
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 70
Frailty and lipid profile in elderly hospitalized patients 69
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 67
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 66
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 65
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 64
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 64
Sindrome di Cushing Subclinico in pazienti in postmenopausa con Osteoporosi 63
Relationship between blood pressure and frailty in older hypertensive outpatients 63
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 63
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 63
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 63
Serum anti-p53 autoantibodies in patients with type 1 diabetes 62
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 62
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 62
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 62
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 62
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 62
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 61
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 61
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 61
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 60
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 60
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 60
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 60
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 60
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 60
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 59
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 59
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 59
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 58
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 58
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 58
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 58
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 57
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 57
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 57
Anxiety levels as risk factor for osteoporosis in postmenopausal women 57
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 57
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 56
Vitamin D status and the relationship with bone fragility fractures in HIV-infected patients: A case control study 56
Stile di vita, invecchiamento e longevità 55
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 55
Disappearance of a virilizing adrenal tumor (VAT), in a woman who had been overtreated with nandrolone, by cyproterone acetate 54
Somministrazione settimanale e giornaliera di alendronato nel trattamento dell'osteoporosi della thalassemia major. 54
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 54
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 54
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 54
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 53
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 53
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 53
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 53
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 53
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 53
Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia (Endocrine, (2019), 65, 3, (569-579), 10.1007/s12020-019-01908-x) 53
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 53
Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women 52
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 52
DISAPPEARANCE OF A VIRILIZING ADRENAL TUMOR FOLLOWING THERAPY WITH CYPROTERONE ACETATE. 52
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 52
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 52
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 52
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 51
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 51
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 51
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 51
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 51
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 51
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 51
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 51
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 50
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 50
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 50
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 49
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 49
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 49
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 49
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 49
Totale 6.224
Categoria #
all - tutte 37.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020840 0 0 0 0 0 182 119 99 43 225 137 35
2020/2021944 80 19 277 54 140 67 29 70 15 100 48 45
2021/20221.303 10 183 21 54 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/2025579 55 58 61 213 180 12 0 0 0 0 0 0
Totale 8.699